Affinity Asset Advisors, LLC Bridge Bio Pharma, Inc. Transaction History

Affinity Asset Advisors, LLC

$560 Million
Q4 2024

A detailed history of Affinity Asset Advisors, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Affinity Asset Advisors, LLC holds 200,000 shares of BBIO stock, worth $6.98 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares

200,000

Previous 300,000 33.33%

Holding current value

$6.98 Million

Previous $7.64 Million 28.15%

% of portfolio

0.98%

Previous 1.32%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$22.35 - $29.5 $2.24 Million - $2.95 Million	-100,000 Reduced 33.33%	200,000 $5.49 Million
Q3 2024 Nov 13, 2024	BUY	$23.91 - $31.3 $4.78 Million - $6.26 Million	200,000 Added 200.0%	300,000 $7.64 Million
Q2 2024 Aug 14, 2024	BUY	$23.0 - $31.04 $1.15 Million - $1.55 Million	50,000 Added 100.0%	100,000 $2.53 Million
Q1 2024 May 14, 2024	SELL	$27.35 - $40.45 $820,500 - $1.21 Million	-30,000 Reduced 37.5%	50,000 $1.55 Million
Q4 2023 Feb 13, 2024	BUY	$24.02 - $43.89 $1.2 Million - $2.19 Million	50,000 Added 166.67%	80,000 $3.23 Million
Q3 2023 Nov 14, 2023	SELL	$16.89 - $35.01 $86,696 - $179,706	-5,133 Reduced 14.61%	30,000 $791,000
Q2 2023 Aug 14, 2023	SELL	$13.29 - $18.01 $3.79 Million - $5.13 Million	-284,867 Reduced 89.02%	35,133 $604,000
Q1 2023 May 15, 2023	BUY	$7.17 - $18.55 $2.29 Million - $5.94 Million	320,000 New	320,000 $5.31 Million
Q1 2022 May 13, 2022	SELL	$7.34 - $17.16 $3.63 Million - $8.48 Million	-494,046 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$11.38 - $53.41 $1.83 Million - $8.57 Million	-160,389 Reduced 24.51%	494,046 $8.24 Million
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $4.89 Million - $6.71 Million	104,435 Added 18.99%	654,435 $30.7 Million
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $1.28 Million - $1.76 Million	-27,500 Reduced 4.76%	550,000 $33.5 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $23.4 Million - $30.6 Million	422,500 Added 272.58%	577,500 $35.6 Million
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $5.95 Million - $11 Million	155,000 New	155,000 $11 Million

Others Institutions Holding BBIO

# of Institutions

321

Shares Held

176M

Call Options Held

13M

Put Options Held

2.48M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $5.17B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Affinity Asset Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Affinity Asset Advisors, LLC with notifications on news.

Account

Affinity Asset Advisors, LLC Bridge Bio Pharma, Inc. Transaction History